Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.

OBJECTIVES: Infants infected with HIV-1 perinatally despite single-dose nevirapine progress rapidly. Data on treatment outcome in sub-Saharan African infants exposed to single-dose nevirapine are urgently required. This feasibility study addresses efficacy of infant antiretroviral therapy in this se...

Descripció completa

Dades bibliogràfiques
Autors principals:	Prendergast, A, Mphatswe, W, Tudor-Williams, G, Rakgotho, M, Pillay, V, Thobakgale, C, McCarthy, N, Morris, L, Walker, B, Goulder, P
Format:	Journal article
Idioma:	English
Publicat:	2008

Ítems similars

High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.
per: Mphatswe, W, et al.
Publicat: (2007)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
per: Gossez, M, et al.
Publicat: (2018)

Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection.
per: Prendergast, A, et al.
Publicat: (2011)

Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection
per: Prendergast, A, et al.
Publicat: (2011)

Approaches towards avoiding lifelong antiretroviral therapy in paediatric HIV infection.
per: Goulder, P, et al.
Publicat: (2011)

Detection of HIV type 1 gag-specific CD4(+) T cell responses in acutely infected infants.
per: Ramduth, D, et al.
Publicat: (2008)

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
per: Kekitiinwa, A, et al.
Publicat: (2017)

Non-progressive paediatric HIV infection is associated with virus attenuation and increase in CD8+specific T cell responses over time
per: Prado, J, et al.
Publicat: (2009)

P07-07. Non-progressive paediatric HIV infection is associated with virus attenuation and increase in CD8+ specific T cell responses over time
per: Prado, J, et al.
Publicat: (2009)

P07-07. Non-progressive paediatric HIV infection is associated with virus attenuation and increase in CD8+ specific T cell responses over time
per: Walker BD, et al.
Publicat: (2009-10-01)

Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
per: Marta Iglis Oliveira, et al.
Publicat: (2018-10-01)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
per: M. Ali Rai, et al.
Publicat: (2022-09-01)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
per: Mulugeta Melku, et al.
Publicat: (2020-08-01)

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
per: Nicola Gianotti, et al.
Publicat: (2017-01-01)

Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.
per: Phillips, A, et al.
Publicat: (2004)

Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants.
per: Thobakgale, C, et al.
Publicat: (2007)

Factors associated with oxidative stress in virologically suppressed people living with HIV on long-term antiretroviral therapy
per: Francesca Lombardi, et al.
Publicat: (2024-12-01)

The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.
per: Michael Rosenblum, et al.
Publicat: (2009-09-01)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda.
per: Alexander Billioux, et al.
Publicat: (2015-01-01)

Virological suppression in children and adolescents is not influenced by genotyping, but depends on optimal adherence to antiretroviral therapy
per: Juliana Costa de Abreu, et al.
Publicat: (2017-05-01)

Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults
per: Eugène Messou, et al.
Publicat: (2008-06-01)

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
per: Francis Kiweewa, et al.
Publicat: (2019-01-01)

Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate.
per: Prado, J, et al.
Publicat: (2010)

Respective roles of migration and social deprivation for virological non-suppression in HIV-infected adults on antiretroviral therapy in France.
per: Mariem Raho-Moussa, et al.
Publicat: (2019-01-01)

Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.
per: Portia C Mutevedzi, et al.
Publicat: (2011-01-01)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
per: Szubert, A, et al.
Publicat: (2017)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
per: P. Zacharopoulou, et al.
Publicat: (2022-01-01)

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
per: Touloumi, G, et al.
Publicat: (2006)

HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study
per: Abraham Aregay Desta, et al.
Publicat: (2020-01-01)

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy
per: Anthony Jaworowski, et al.
Publicat: (2019-06-01)

Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda
per: Adah Tumwegamire, et al.
Publicat: (2024-01-01)

Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia
per: Plymoth, M, et al.
Publicat: (2020)

Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana.
per: Katherine T Steele, et al.
Publicat: (2011-01-01)

Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia.
per: Martin Plymoth, et al.
Publicat: (2020-01-01)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
per: Alexander J Szubert, et al.
Publicat: (2017-11-01)

Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
per: Szubert, A, et al.
Publicat: (2015)

Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
per: Julie Kadima, et al.
Publicat: (2018-01-01)

HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
per: Nyongesa, MK, et al.
Publicat: (2022)

HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
per: Moses K. Nyongesa, et al.
Publicat: (2022-05-01)

Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment.
per: Bhavna H Chohan, et al.
Publicat: (2021-01-01)